EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy

Liang Li, Si-Rui Ma, Zi-Li Yu

Cellular Oncology · 2024-04 · 47 (2) · 415-428

DOI: 10.1007/s13402-023-00881-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Oncology, online erschienen am 30.09.2023. Verfasst von Liang Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Lipid Metabolism, Immunotherapy, Neoplasms, Tumor-Associated Macrophages. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Tumor-associated macrophages, as the major immunocytes in solid tumors, show divided loyalty and remarkable plasticity in tumorigenesis. Once the M2-to-M1 repolarization is achieved, they could be switched from the supporters for tumor development into the guardians for host immunity. Meanwhile, Lipid metabolic reprogramming is demonstrated to be one of the most important hallmarks of tumor-associated macrophages, which plays a decisive role in regulating their phenotypes and functions to promote tumorigenesis and immunotherapy resistance. Therefore, targeting the lipid metabolism of TAMs may provide a new direction for anti-tumor strategies. CONCLUSION: In this review, we first summarized the origins, classifications and general lipid metabolic process of TAMs. Then we discussed the currently available drugs and interventions that target lipid metabolic disorders of TAMs, including those targeting lipid uptake, efflux, lipolysis, FAO and lipid peroxidation. Besides, based on the recent research status, we summarized the present challenges for this cancer immunotherapy, including the precise drug delivery system, the lipid metabolic heterogeneity, and the intricate lipid metabolic interactions in the TME, and we also proposed corresponding possible solutions. Collectively, we hope this review will give researchers a better understanding of the lipid metabolism of TAMs and lead to the development of corresponding anti-tumor therapies in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismImmunotherapyNeoplasmsTumor-Associated MacrophagesHumansAnimalsTumor MicroenvironmentMetabolic Reprogramming

Stichwörter der Autor:innen

Cancer immunotherapyImmunometabolismLipid metabolismTumor microenvironmentTumor-associated macrophages

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
  • Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, Wuhan, 430079, China. masirui@whu.edu.cn.
  • Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, Wuhan, 430079, China. zili09@whu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, L., Ma, S. R., & Yu, Z. L. (2024). Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy. Cellular Oncology, 47(2), 415-428. https://doi.org/10.1007/s13402-023-00881-y

Vancouver

Li L, Ma SR, Yu ZL. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy. Cellular Oncology. 2024;47(2):415-428. doi:10.1007/s13402-023-00881-y

BibTeX
@article{Li2024,
  author = {Li, Liang and Ma, Si-Rui and Yu, Zi-Li},
  title = {Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy},
  journal = {Cellular Oncology},
  year = {2024},
  volume = {47},
  number = {2},
  pages = {415--428},
  doi = {10.1007/s13402-023-00881-y}
}
Kostenlos starten →